FDA Authorizes COVID Vaccine For 5-11 Year Olds: Trials For 6 Month Old Infants Underway
www.thepulse.one
The United States Food and Drug Administration (FDA) has issued emergency use authorization of the Pfizer vaccine for children ages 5-11. CNN explains, "Pfizer says a clinical trial showed its vaccine provides more than 90% protection against symptomatic disease among children, even at one-third the dose, and the company hopes the lower dose will reduce the risk of any side effects."
FDA Authorizes COVID Vaccine For 5-11 Year Olds: Trials For 6 Month Old Infants Underway
FDA Authorizes COVID Vaccine For 5-11 Year…
FDA Authorizes COVID Vaccine For 5-11 Year Olds: Trials For 6 Month Old Infants Underway
The United States Food and Drug Administration (FDA) has issued emergency use authorization of the Pfizer vaccine for children ages 5-11. CNN explains, "Pfizer says a clinical trial showed its vaccine provides more than 90% protection against symptomatic disease among children, even at one-third the dose, and the company hopes the lower dose will reduce the risk of any side effects."